ST-Elevation Myocardial Infarction
Conditions
Brief summary
The program is to improve STEMI medical care quality in China. With the documents issued by National Health and Family Planning Commission of the People's Republic of China, the program was initialed in at least 200 primary PCI capable hospitals together with hundreds of adjacent non-primary PCI capable hospitals in 15 provinces. STEMI patients with symptom onset within 30 days will be enrolled in 3 periods. In each period with 6-month interval, 30 patients will be enrolled consecutively from each PCI-capable center initially and from non-primary PCI capable hospitals later, thus at least 18,000 STEMI patients from primary PCI capable hospitals will be enrolled and all of them will be followed up for 1 year. Key performance indicators (KPIs) in STEMI care will be collected using both national PCI online registry and a program STEMI online registry database for the purpose of improvement of medical care. Hospital KPIs rank report and problem-based resolution will be feedback to each hospital after data analysis in each period. Comparison of every two cross-sectional data (self) and within one cross-sectional (inter-hospital) data will be used to evaluate the improvement of medical quality.
Interventions
OTHERclinical pathway
Sponsors
Chinese Medical Doctor Association
Peking University First Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* STEMI patients with symptom onset within 30 days
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Referfusion ratio in patients with symptom onset within 12 hours | 12 hours | Referfusion including primary PCI and thrombolysis is the key strategy in STEMI care |
| Door-to-ballnoon time in patients with symptom onset within 12 hours | 12 hours | Door-to-ballnoon time is the key index to evaluate treatment of primary PCI |
| Door-to-needle time in patients with symptom onset within 12 hours | 12 hours | Door-to-needle time is the key index to evaluate treatment of thrombolysis |
| Hospital admission via ambulance ratio | 2 years | — |
| Symptom onset to arrive in hospital | 2 years | — |
| Bypass ED ratio in patients with symptom onset within 12 hours | 12 hours | — |
| Usage of both DAPT, statin, β blocker and ACEI/ARB in patients without contraindication | 3 yeras | DAPT means dual antiplatelet therapy |
| In-hospital morbidity | 2 yeras | — |
| 1-year on time follow-up ratio | 1 year | — |
Countries
China
Contacts
Primary ContactYan Zhang, MD
Outcome results
None listed